Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Article(6)
Publisher
American Heart Journal(2)
Circulation(1)
JAMA Cardiology(1)
JAMA Neurology(1)
The Lancet Diabetes and Endocrinology(1)
Área temáticas
Enfermedades(5)
Medicina y salud(5)
Farmacología y terapéutica(3)
Problemas sociales y servicios a grupos(2)
Fisiología humana(1)
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., da Silva B.G.P., Damiani L.P., De Andrade Jesuíno I., De Salles A., Freitas G.R.d., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Peterson E.D., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusEffect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Studies have found that patients at high cardiovascular risk often fail to receive evidePalabras claves:Autores:Almeida A.S., Amodeo C., Baldissera V., Baréa J.A.B., Barros E Silva P.G.D.M., Barroso S.L., Becke G.C.M., Bergo R.R., Berwanger O., Brandão Da Silva N., Campos V.B., Caron V., Conte D., Corrêa J.V.S., da Silva N.B., da Silva S.S., da Silva Serra K.C.C., da Silveira L., da Veiga V.d.F.N., Damiani L.P., Dantas J.M.M., de Assis R.M., de Barros E.F., de Figueiredo Neto J.A., de Moraes J.B.d.M.X., de Oliveira Silveira M.G., del Monaco M.I., do Brasil C.K.O.I., do Canto Filho M.J., do Carmo J.B., Domingues L.H., dos Santos E.V., dos Santos J.C., Duro L.N., Esper R.B., Esteves M.W., Feier A.P., Fernandes L.A.B., Filho J.A.S.B., Fonseca F.H., Fortes J.A.R., Gomes S.P.D.C., Gonçalves M.R., Gonzales B.P., Grezzana G.B., Guerra S.D., Guimarães H.P., Izar M.C., Jardim P.C.B.V., Kodama A., Kopittke L., Leães P.E., Lopes C.D., Lopes R.D., Lourenço S., Luiz R.O., Machline-Carrion M.J., Marcela G.d.O.A., Martin J.F.V., Martins G.L., Moraes M.J.D., Nakagawa R.H., Neto E.L., Neves M.F., Nobre F., Octavio Marques Pontes-Neto, Ormundo C., Orto F.T.C.D., Osugue R.K., Pauli C., Piegas L.S., Pinheiro S., Precoma D.B., Ramacciotti E., Ribeiro G.R., Rocha M.d.F., Sampaio B., Santo J.C.M.D.A., Santos J.Y., Santos P.D., SARAIVA J.O.S.E., Sehnem E., Silva A.L., Silva L.d.O., Silva L.P.W., Silva T.P., Silveira F.S., Sirena S.A., Soares R.M., Sousa A.L.L., Souza S.d.A.R., Stein A.T., Tobias J.S.P., Trama L.M., Vicente C.C., Wanderley F.F., Werle L., Woehl J., Ziebell J.V.Fuentes:scopusEffect of a Quality Improvement Intervention on Adherence to Therapies for Patients with Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit M.C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., Damiani L.P., De Andrade Jesuíno I., De Salles A., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Pacheco Da Silva B.G., Peterson E.D., Rodrigues De Freitas G., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusEffects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
ArticleAbstract: Background: After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovasculPalabras claves:Autores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Baccara-Dinet M.T., Bhatt D.L., Bittner V.A., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Colhoun H.M., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., DIaz R., Dilic M., Dorobantu M., Drexel H., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Landmesser U., Laucevicius A., Lecorps G., Liberopoulos E., Loizeau V., Lopes R.D., Mahaffey K.W., Marx N., Meloni C., Montenegro Valdovinos P.C., Morais J., Moriarty P.M., Moryusef A., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Prieto J.C., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:googlescopusRationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of high cardiovascular risPalabras claves:Autores:Amodeo C., Berwanger O., Brandão Da Silva N., Campos V.B., Damiani L.P., de Melo Barros P.G., Fonseca F.H., Guimarães H.P., Izar M.C., Lopes R.D., Machline-Carrion M.J., Octavio Marques Pontes-Neto, Piegas L.S., Sampaio B., Soares R.M., Stein A.T., Yamashita J.Fuentes:scopusRisk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
ArticleAbstract: Background: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapPalabras claves:acute coronary syndrome, alirocumab, dyslipidemias, GUIDELINEAutores:Baccara-Dinet M.T., Bhatt D.L., Bittner V.A., DIaz R., Goodman S.G., Harrington R.A., Jukema J.W., Li Q.H., Lopes R.D., Louie M.J., Moriarty P.M., PATRICIO LOPEZ -JARAMILLO, Roe M.T., Schwartz G.G., Steg P.G., Szarek M., Vogel R., White H.D., Zeiher A.M.Fuentes:googlescopus